Skip to main content

Sygnis Inks Belgian Distribution Agreement with Sopachem for TruePrime

NEW YORK (GenomeWeb) – Sygnis today announced a non-exclusive distribution agreement with Sopachem for the commercialization of TruePrime products.

Under the terms of the agreement, Sopachem will promote, market, sell, and support TruePrime products for primer-free whole genome amplification in Belgium.

TruePrime products use Sygnis' multiple displacement amplification technology based on DNA primase TthPrimPol and Phi29 polymerase.

Belgium-based Sopachem is a specialized distributor with a focus on life sciences, diagnostics, and biobanking. The firm also has operations in the Netherlands and Luxembourg.

Since the beginning of the year, Sygnis has signed international distribution partnerships in Spain, Canada, Japan, and France.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.